Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Silo Pharma, Inc.
On October 13, 2026, Silo Pharma, Inc. entered into an asset purchase agreement to acquire software and intellectual property related to 'Reputation Endpoints' from Larry King. The company issued 150,000 shares of common stock as consideration, which are subject to a 12-month lock-up period.…more
Silo Pharma, Inc.
Silo Pharma has entered into an asset purchase agreement to acquire software and intellectual property from Norsight Consulting. In consideration, the company issued a warrant to purchase up to 300,000 shares of common stock with an exercise price of $1.51, subject to a 12-month lock-up period.…more
Silo Pharma, Inc.
On August 18, 2026, Silo Pharma entered into an asset purchase agreement with Parkview Consulting LLC to acquire software, technology, and intellectual property. As consideration, the company issued 165,000 shares of its common stock, which are subject to a 12-month lock-up period.…more
21 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
Silo Pharma to Acquire Software and IP from Larry King
Silo Pharma has agreed to acquire software and related intellectual property from Larry King. The company will issue 150,000 shares as consideration for the acquisition.…more
●●●●●●●● ●●●●● ●●●●●●
Silo Pharma has entered into an agreement to purchase software and intellectual property assets from Norsight Consulting. The company issued warrants as consideration, which introduces potential share dilution for existing shareholders.…more
●●●●●●●● ●●●●● ●●●●●●
Silo Pharma's subsidiary QwikAgents has expanded its AI platform by adding support for NVIDIA models and new runtime flexibility. While this update enhances customer choice, there is no immediate financial impact or revenue guidance provided.…more
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.